Resultats de la cerca - Faramarz Ismail‐Beigi
- Mostrar 1 - 20 resultats de 50
- Anar a la pàgina següent
-
1
Clinical Implications of the ACCORD Trial per Saul Genuth, Faramarz Ismail‐Beigi
Publicat 2011Revisão -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
The effect of sodium-glucose co-transporter-2 (SGLT2) inhibitors on blood interleukin-6 concentration: a systematic review and meta-analysis of randomized controlled trials per Sepehr Gohari, Faramarz Ismail‐Beigi, Mahsa Mahjani, Saeed Ghobadi, Alireza Jafari, Hassan Ahangar, Sheida Gohari
Publicat 2023Revisão -
18
Effect of Empagliflozin on Liver Steatosis and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease Without Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial per Hoda Taheri, Mojtaba Malek, Faramarz Ismail‐Beigi, Farhad Zamani, Masoudreza Sohrabi, Mohammad Reza Babaei, Mohammad E. Khamseh
Publicat 2020Artigo -
19
-
20
Eines de cerca:
Matèries relacionades
Endocrinology
Medicine
Internal medicine
Diabetes mellitus
Type 2 diabetes
Insulin
Biology
Chemistry
Intensive care medicine
Biochemistry
Insulin resistance
Randomized controlled trial
Confidence interval
Disease
Glycemic
Gene
Alternative medicine
Hazard ratio
Hypoglycemia
Organic chemistry
Pathology
Placebo
Cardiology
Cell biology
Environmental health
Kidney disease
Population
Diabetic retinopathy
Empagliflozin
Engineering